谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Tables 1 - 2, Figure 1 from A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Vincent Ribrag, Jehan Dupuis,Herve Tilly,Franck Morschhauser, Fabrice Laine,Roch Houot,Corinne Haioun,Christiane Copie,Andrea Varga,John Lambert,Laurence Hatteville,Samira Ziti-Ljajic,Anne Caron,Sandrine Payrard,Bertrand Coiffier

crossref（2023）

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要